SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Young and Older Folk Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: chowder4/18/2025 1:55:41 PM
3 Recommendations

Recommended By
Markbn
Menominee
Mili21

   of 22988
 
I have done well with LLY over the last few years. I started adding to it again this year. I also opened new positions in JNJ early this year and NFLX most recently. YTD the stocks have upside momentum.

Eli Lilly & Co. ( LLY) announced Friday that it plans to manufacture its experimental weight-loss pill in the U.S. as President Trump emphasizes reshoring manufacturing to the U.S.

“We’re going to make this medicine here in the United States,” Chief Executive Officer Dave Ricks said Friday in an interview with Fox Business Network’s Maria Bartiromo. “We’ll be proud to make this medicine at that site and ship it around the world from our country.”

Eli Lilly (NYSE: LLY) shares closed 14% higher yesterday after the company said its oral GLP-1 receptor agonist orforglipron reached the main goal in a Phase 3 trial for adults with type 2 diabetes.



Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News